CD8A and infection: In order to determine CD8 T cell-mediated protection and avoid the contribution of non-CD8 T cell protective responses potentially induced by previous infections (36–38), we exposed mice to IN challenge with a high dose (107 PFU) of recombinant vaccinia virus expressing full-length influenza PR8 NP (Vac-NP) (Figure 2A).